Ovid Therapeutics
OVID
OVID
81 hedge funds and large institutions have $153M invested in Ovid Therapeutics in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.41% less ownership
Funds ownership: 73.28% → 70.87% (-2.4%)
8% less capital invested
Capital invested by funds: $167M → $153M (-$13.9M)
Holders
81
Holding in Top 10
2
Calls
$28K
Puts
$1K
Top Buyers
| 1 | +$3.29M | |
| 2 | +$746K | |
| 3 | +$488K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$456K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$385K |
Top Sellers
| 1 | -$10M | |
| 2 | -$562K | |
| 3 | -$417K | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$275K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$273K |